Expertise in
1
conditions

Salvatore Cazzato

Ancona, IT 
Expertise in
1
conditions
Ancona, IT 

Overview

Salvatore Cazzato practices practicing medicine in Ancona, Italy.

Mr. Cazzato is highly rated in 1 condition, according to our data. His clinical expertise encompasses Osteopetrosis Autosomal Recessive Type 3, Multisystem Inflammatory Syndrome in Children (MIS-C), Primary Lateral Sclerosis, and Childhood Pancreatitis.

He is actively involved in clinical research, co-authoring 43 peer reviewed articles and participating in 1 clinical trial.

Gender

Male

Locations

Ancona, Italy
Other Locations
Como, Italy
Marche, Italy
Bologna, Italy

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Randomised, Double-blind, Parallel Group, Multicentre, Stratified, Study Evaluating the Efficacy and Safety of Once Daily Fluticasone Furoate/Vilanterol Inhalation Powder Compared to Once Daily Fluticasone Furoate Inhalation Powder in the Treatment of Asthma in Participants Aged 5 to 17 Years Old (Inclusive) Currently Uncontrolled on Inhaled Corticosteroids
A Randomised, Double-blind, Parallel Group, Multicentre, Stratified, Study Evaluating the Efficacy and Safety of Once Daily Fluticasone Furoate/Vilanterol Inhalation Powder Compared to Once Daily Fluticasone Furoate Inhalation Powder in the Treatment of Asthma in Participants Aged 5 to 17 Years Old (Inclusive) Currently Uncontrolled on Inhaled Corticosteroids
Enrollment Status: Completed
Publish Date: June 22, 2025
Intervention Type: Drug
Study Drugs: Fluticasone Furoate, Vilanterol
Study Phase: Phase 3

43 Total Publications

Heterogeneous Reduction in Paediatric RSV Hospitalisations Following Regional Nirsevimab Immunisation Strategies: A Multicentre Study.
Heterogeneous Reduction in Paediatric RSV Hospitalisations Following Regional Nirsevimab Immunisation Strategies: A Multicentre Study.
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: May 02, 2026

Frequently Asked Questions about Salvatore Cazzato

Is Salvatore Cazzato a top-rated expert for Osteopetrosis Autosomal Recessive Type 3?

MediFind is an objective health platform that identifies experts based on real-world data. Salvatore Cazzato is classified as an Advanced expert for Osteopetrosis Autosomal Recessive Type 3, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Salvatore Cazzato participate in research or clinical trials?

Yes. Salvatore Cazzato has published 43 articles and abstracts on conditions like Osteopetrosis Autosomal Recessive Type 3. You can view a list of Salvatore Cazzato's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Cazzato's expertise for a condition
ConditionClose
      View All 23 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile